1 |
Bocci V. 1993. Mistletoe (Viscum album) lectins as cytokine
inducers and immuniadjuvant in tummor therapy. A review.
J Biol Regul Homeost Agents 7: 1-6.
|
2 |
Joller PW, Menrad JM, Schwarz T, Pfueller U, Parnham MJ,
Weyhenmeyer R, Lentzen H. 1996. Stimulation of cytokine production via a special standardized mistletoe preparation in an in vitro human skin bioassay. Arzneimittel-Forschung/Drug Res 46: 649-653.
|
3 |
Yoon TJ, Yoo YC, Kang TB, Baeck YJ, Huh CS, Song SK,
Lee KH, Azuma I, Kim JB. 1998. Prophylactic effect of Korean
mistletoe (Viscum album coloratum) extract on tumor metastasis
is mediated by enhancement of NK cell activity. International
J Immunopharmacology 20: 163-172.
DOI
ScienceOn
|
4 |
Bloksma N, Dijk HV, Korst P, Willers JM. 1979. Cellular and
Humoral adjuvant activity of a mistletoe extract. Immunobiol
156: 309-319.
|
5 |
Yoon HJ, Kim JH, Jang JJ. 1996. Effect of sardine oil feeding and vitamin E supplementation on the preneoplastic hepatic lesion and cholesterol metabolism in hepatocarcinogenesis of rats. J Food Sci Nutr 1: 214-219.
과학기술학회마을
|
6 |
Franz H. 1986. Mistletoe lectins and their A and B chains. Oncology
43 (suppl. 1): 23-34.
|
7 |
Doser C, Doser M, Huelsen H, Mechelke F. 1989. Influence of
carbohydrates on the cytotoxicity of an aqueous mistletoe
drug and of purified mistletoe lectins tested on human Tleukemia
cells. Arzneimittel-Forschung/Drug Res 39: 647-651.
|
8 |
Klett CY, Anderer FA. 1989. Activation of natural killer cell cytotoxicity of human blood monocytes by a low molecular component from Viscum album extract. Arzneimittel-Forschung/Drug Res 39 (II): 1580-1585.
|
9 |
Janeway CA, Travers P, Walport M, Shlomchik M. 2001.
Immunobiology; The immune system in health and disease.
5th ed. Garland publishing, a member of the Taylor & Francis group, New York. p 209-217.
|
10 |
Khwaja TA, Dias CB, Pentecost S. 1986. Recent studies on
the anticancer activities mistletoe (Viscum album) and its
alkaloids. Oncology 43 (suppl. 1): 42-50.
DOI
|
11 |
Timoshenko AV, Gabius HJ. 1993. Efficient induction of superoxide release from human neutrophils by the galactosidespecific lectin from Viscum album. Biol Chem Hoppe-Seyler
374: 237-243.
DOI
ScienceOn
|
12 |
Schink M. 1997. Mistletoe therapy for human cancer: the role
of natural killer cells. Anti-Cancer Drugs 8 (suppl. 1): s47-s51.
DOI
|
13 |
Steiner R. 1920. Spiritual sciences and medicine. Rudolf Steiner Publishing Co., London.
|
14 |
Ribereau-Gayon G, Jung ML, Baudino S, Salle G, Beck JP.
1986. Effect of mistletoe (Viscum album L.) extracts on cultured
tumor cells. Experientia 42: 594-599.
DOI
ScienceOn
|
15 |
Kim MJ, Kim JH. 2001. Anti-carcinogenic effects of Korean mistletoe extract and lectin in experimental hepatocarcinogenesis.
J Korean Soc Food Sci Nutr 30: 697-702.
과학기술학회마을
|
16 |
Jang JJ, Lee MS, Kim TH. 1994. Development of GST- foci in 3 week old rats induced by diethylnitrosamine: preliminary data for liver foci model. J Korean Cancer 26: 23-235.
|
17 |
Hsu SM, Raine L, Fanger H. 1981. Use of avidine-biotin peroxidase complex (ABC) in immunoperoxidase techniques:a comparison between ABC and unlabeled antibody (PAP) procedure. J Histochem Cytochem 29: 577-580.
DOI
ScienceOn
|
18 |
Schumacher U, Stamouli A, Adam E, Peddie M, Pfuller U. 1995.
Biochemical, histochemical and cell biological investigations
on the actions of mistletoe lectins I, II and III with human
breast cancer cell lines. Glycoconjugte Journal 12: 250-257.
DOI
ScienceOn
|